Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.2K
Spermatogenesis01:41

Spermatogenesis

124.9K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.9K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.6K
Cancer02:18

Cancer

56.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.

Annals of surgical oncology·2025
Same author

Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.

Annals of surgical oncology·2025
Same author

Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.

The oncologist·2021

Related Experiment Video

Updated: Apr 12, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.6K

Germ cell tumors: looking to the future.

George J Bosl1

  • 1From the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|May 21, 2015
PubMed
Summary
This summary is machine-generated.

Long-term health risks, including vascular disease and secondary cancers, are observed in men treated for germ cell tumors (GCTs). Lifelong surveillance is crucial for detecting late effects and relapses in GCT survivors.

More Related Videos

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.6K
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.8K

Area of Science:

  • Oncology
  • Cancer Biology
  • Clinical Management

Background:

  • Germ cell tumors (GCTs) management and biology are continually advancing.
  • Long-term toxicities post-GCT treatment mirror those in Hodgkin lymphoma survivors.
  • Delayed effects and late relapse necessitate lifelong surveillance for GCT patients.

Purpose of the Study:

  • To highlight evolving knowledge in GCT management and tumor biology.
  • To emphasize the importance of informing patients about short-term and long-term treatment effects.
  • To underscore the need for continuous monitoring of GCT survivors for late outcomes.

Main Methods:

  • Review of current literature on GCT management and outcomes.
  • Analysis of treatment-related toxicities and their latency patterns.
  • Evaluation of the clinical relevance of GCT biology, including programmed differentiation.

Main Results:

  • Vascular disease, metabolic syndrome, secondary cancers, and hypogonadism are significant late effects of GCT treatment.
  • Multicenter trials involving the broader oncology community can improve outcomes for high-risk and relapsed GCT patients.
  • Programmed differentiation in GCTs is a key biological factor potentially linked to chemotherapy resistance.

Conclusions:

  • GCT survivors require comprehensive, lifelong surveillance for diverse late adverse effects and potential relapse.
  • Integrating general oncology expertise into GCT trials can enhance treatment efficacy for challenging cases.
  • Understanding GCT primordial germ cell origin and programmed differentiation offers clinical insights for improved therapeutic strategies.